Replies to post #155160 on Anavex Life Sciences Corp (AVXL)

[ven69]

Melbourne leads international trial of Anavex 2-73 for mild-moderate Alzheimer's, after promising phase II study that improved cognition, memory and mood
Herald Sun - 1 hour ago

Does someone have a herald sun membership, this was also released this morning.

[Turner2017]

Finally some good news! Wohoo!!!

[HMB2010]

Yay !!!!! There is light in the darkness of this dreadful disease!

[LakeshoreLeo1953]

That will make the short leg today interesting.
Trying to beat the heat and you find this BLAST FURNACE
PR.

Hmmmmmmmm.

[nidan7500]

BAM>>>BAM>>>BAM....NICE....just as hoped, a model trial for Precision Medicine....My guess is AAIC will want to know ALL about this....

The ANAVEX(R)2-73 Phase 2b/3 study design includes genomic precision medicine biomarkers identified in the ANAVEX(R)2-73 Phase 2a study. Primary and secondary endpoints will assess safety and both cognitive and functional efficacy, measured through ADAS-Cog, ADCS-ADL and CDR-SB. ANAVEX(R)2-73 Phase 2a Alzheimer's disease study previously demonstrated dose dependent improvement in exploratory endpoints of cognition (MMSE) and function (ADCS-ADL).

As they say in Australia...this takes stones, a MICRO BIO will lead the way after decades of BP consecutive failures and all they can do is WATCH AND LEARN...